Buy or sell Syapse stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Syapse Stock

Real-World Evidence Company

Founded

2008

Notable Investors

Social Capital

Headquarters

San Francisco CA, US

Total Funding

$120M

About Syapse Stock

Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.

Investors

Ascension Ventures

Olive, Reputation.com, Syapse, Wagestream

Intermountain Healthcare Innovation Fund

Armis Security, Syapse

Medidata Solutions

Syapse, AllStripes

Merck Global Health Innovation Fund

Syapse, ClearDATA, Volansi

Revelation Partners

Syapse, Nuvolo

Roche Venture Fund

Freenome, Syapse, Jasper Therapeutics

Safeguard Scientifics

MediaMath, Syapse, Aktana

Social Capital Partners

Syapse

Funding History

January 2011$1.6M
January 2013$3.0M
July 2014$10.0M
January 2016$25.0M
November 2017$30.0M
January 2019$20.0M
May 2020$30.0M

Management

Chief Executive Officer

Ken Tarkoff

Chief Financial Officer

Fletcher Payne

Chief Technology Officer

Tony Loeser

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo